# Nutrien Ltd.: overview NTR · NYSE · CIK 1725964 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ntr.md) · [Financials](/companies/ntr/financials.md) · [Filings](/companies/ntr/filings.md) · [Insiders](/companies/ntr/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [27.7](/filings/0001193125-23-048055.md) | [37.9](/filings/0001193125-24-055096.md) | [29.1](/filings/0001193125-25-041502.md) | [26.0](/filings/0001193125-26-081326.md) | [26.9](/filings/0001193125-26-081326.md) | | Gross margin | % | [34.0%](/filings/0001193125-23-048055.md) | [40.7%](/filings/0001193125-24-055096.md) | [29.2%](/filings/0001193125-25-041502.md) | [29.0%](/filings/0001193125-26-081326.md) | [31.0%](/filings/0001193125-26-081326.md) | | Operating margin | % | [17.3%](/filings/0001193125-23-048055.md) | [28.5%](/filings/0001193125-24-055096.md) | [9.4%](/filings/0001193125-25-041502.md) | [7.1%](/filings/0001193125-26-081326.md) | [13.9%](/filings/0001193125-26-081326.md) | | Net margin | % | [11.4%](/filings/0001193125-23-048055.md) | [20.2%](/filings/0001193125-24-055096.md) | [4.3%](/filings/0001193125-25-041502.md) | [2.6%](/filings/0001193125-26-081326.md) | [8.4%](/filings/0001193125-26-081326.md) | | Diluted EPS | $ per share | [5.52](/filings/0001193125-23-048055.md) | [14.18](/filings/0001193125-24-055096.md) | [2.53](/filings/0001193125-25-041502.md) | [1.36](/filings/0001193125-26-081326.md) | [4.66](/filings/0001193125-26-081326.md) | | Free cash flow | $bn | [2.1](/filings/0001193125-23-048055.md) | [5.9](/filings/0001193125-24-055096.md) | [2.7](/filings/0001193125-25-041502.md) | [1.5](/filings/0001193125-26-081326.md) | [2.1](/filings/0001193125-26-081326.md) | - Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ntr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $2.07bn | 32,897,258 | | Added +1,887,589 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $928.6m | 14,739,325 | | Reduced −10,201 | | [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $868.4m | 13,797,719 | | Added +912,993 | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $654.1m | 10,389,040 | | Reduced −5,703,675 | | [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $627.7m | 9,971,263 | | Reduced −17,604 | | [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $627.7m | 9,971,263 | | Reduced −17,604 | | [DEUTSCHE BANK AG\\](/funds/948046.md) | 2026-06-30 | $588.7m | 9,352,182 | | Added +817,421 | | [1832 Asset Management L.P.](/funds/944388.md) | 2026-06-30 | $452.3m | 7,184,426 | | Added +780,603 | | [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $430.8m | 6,837,571 | | Added +202,803 | | [TD Asset Management Inc](/funds/1056053.md) | 2026-06-30 | $422.7m | 6,711,138 | | Reduced −2,549,597 | ## Recent filings [All 319 filings](/companies/ntr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-05 | 12:59 ET | [6-K](/filings/0001193125-26-413251.md) | Report of a foreign private issuer, period 2026-10-05 | 0001193125-26-413251 | | 2026-08-06 | 01:54 ET | [6-K](/filings/0001193125-26-336192.md) | Report of a foreign private issuer, period 2026-08-05 | 0001193125-26-336192 | | 2026-08-05 | 21:24 ET | [6-K](/filings/0001193125-26-335517.md) | Report of a foreign private issuer, period 2026-08-05 | 0001193125-26-335517 | | 2026-07-14 | 21:40 ET | [6-K](/filings/0001193125-26-302188.md) | Report of a foreign private issuer, period 2026-07-13 | 0001193125-26-302188 | | 2026-06-15 | 21:39 ET | [6-K](/filings/0001193125-26-269768.md) | Report of a foreign private issuer, period 2026-06-12 | 0001193125-26-269768 | | 2026-05-29 | 20:43 ET | [6-K](/filings/0001193125-26-248515.md) | Report of a foreign private issuer, period 2026-05-28 | 0001193125-26-248515 | | 2026-05-27 | 21:11 ET | [6-K](/filings/0001193125-26-242151.md) | Report of a foreign private issuer, period 2026-05-27 | 0001193125-26-242151 | | 2026-05-27 | 00:35 ET | [6-K](/filings/0001193125-26-239965.md) | Report of a foreign private issuer, period 2026-05-26 | 0001193125-26-239965 | | 2026-05-07 | 01:46 ET | [6-K](/filings/0001193125-26-209878.md) | Report of a foreign private issuer, period 2026-05-06 | 0001193125-26-209878 | | 2026-05-07 | 21:41 ET | [6-K](/filings/0001193125-26-209499.md) | Report of a foreign private issuer, period 2026-05-06 | 0001193125-26-209499 | ## Latest annual report [Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-081326.md), filed Feb 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1725964 - Tickers: NTR - Exchange: NYSE - SIC code: 2870 Agricultural Chemicals - State of incorporation: Z4 - Filer category: not reported Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.